Evogene Schedules Second Quarter 2024 Financial Results Release
Evogene (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science product discovery and development, has announced the release date for its second quarter 2024 financial results. The results will be published on Thursday, August 22, 2024, followed by a conference call hosted by the company's management at 9:00 AM Eastern Time (4:00 PM Israel time) on the same day.
Interested parties can register in advance for the conference call using the provided Zoom link. The company will also make the entire conference available on its website a few days after the event, ensuring accessibility for those unable to attend the live call.
Evogene (Nasdaq: EVGN) (TASE: EVGN), un leader nel campo della biologia computazionale focalizzato sulla rivoluzione della scoperta e dello sviluppo di prodotti nel settore delle scienze della vita, ha annunciato la data di pubblicazione dei risultati finanziari del secondo trimestre 2024. I risultati saranno pubblicati giovedì 22 agosto 2024, seguiti da una conferenza telefonica ospitata dal management dell'azienda alle 9:00 AM Eastern Time (4:00 PM ora di Israele) lo stesso giorno.
Le parti interessate possono registrarsi in anticipo per la conferenza telefonica utilizzando il link Zoom fornito. L'azienda renderà inoltre disponibile l'intera conferenza sul proprio sito web pochi giorni dopo l'evento, garantendo accessibilità a coloro che non possono partecipare alla chiamata dal vivo.
Evogene (Nasdaq: EVGN) (TASE: EVGN), una compañía líder en biología computacional centrada en revolucionar el descubrimiento y desarrollo de productos en ciencias de la vida, ha anunciado la fecha de publicación de sus resultados financieros del segundo trimestre de 2024. Los resultados se publicarán el jueves 22 de agosto de 2024, seguidos de una conferencia telefónica organizada por la dirección de la empresa a las 9:00 AM Eastern Time (4:00 PM hora de Israel) el mismo día.
Las partes interesadas pueden registrarse con anticipación para la conferencia telefónica utilizando el enlace de Zoom proporcionado. La empresa también hará disponible la conferencia completa en su sitio web unos días después del evento, asegurando accesibilidad para quienes no puedan asistir a la llamada en vivo.
Evogene (Nasdaq: EVGN) (TASE: EVGN)는 생물정보학 분야의 선도 기업으로, 생명과학 제품 발견 및 개발의 혁신을 목표로 하고 있으며, 2024년 2분기 재무 결과 발표 날짜를 발표했습니다. 결과는 2024년 8월 22일 목요일에 발표되며, 같은 날 동부 표준시 오전 9:00 (이스라엘 시간 오후 4:00)에 회사 경영진이 주최하는 컨퍼런스 콜이 진행됩니다.
관심 있는 개인은 제공된 Zoom 링크를 통해 사전 등록할 수 있습니다. 또한 회사는 이벤트가 끝난 후 며칠 내에 전체 컨퍼런스를 웹사이트에 게시하여 실시간 통화에 참여할 수 없는 사람들에게도 접근할 수 있도록 할 것입니다.
Evogene (Nasdaq: EVGN) (TASE: EVGN), une entreprise leader en biologie computationnelle axée sur la révolution de la découverte et du développement de produits en sciences de la vie, a annoncé la date de publication de ses résultats financiers pour le deuxième trimestre 2024. Les résultats seront publiés le jeudi 22 août 2024, suivis d'une conférence téléphonique animée par la direction de l'entreprise à 9h00, heure de l'Est (16h00, heure d'Israël) le même jour.
Les parties intéressées peuvent s'inscrire à l'avance pour la conférence téléphonique en utilisant le lien Zoom fourni. L'entreprise mettra également l'intégralité de la conférence à disposition sur son site web quelques jours après l'événement, garantissant ainsi l'accessibilité à ceux qui ne peuvent pas assister à l'appel en direct.
Evogene (Nasdaq: EVGN) (TASE: EVGN), ein führendes Unternehmen im Bereich der computerbasierten Biologie, das sich darauf konzentriert, die Entdeckung und Entwicklung von Produkten im Bereich der Lebenswissenschaften zu revolutionieren, hat das Veröffentlichungsdatum seiner finanziellen Ergebnisse für das zweite Quartal 2024 angekündigt. Die Ergebnisse werden am Donnerstag, 22. August 2024 veröffentlicht, gefolgt von einer Telefonkonferenz, die am selben Tag um 9:00 Uhr Eastern Time (16:00 Uhr israelischer Zeit) von der Unternehmensleitung geleitet wird.
Interessierte Parteien können sich im Voraus über den bereitgestellten Zoom-Link für die Telefonkonferenz registrieren. Das Unternehmen wird auch die gesamte Konferenz einige Tage nach der Veranstaltung auf seiner Website zur Verfügung stellen, um sicherzustellen, dass auch diejenigen, die nicht an dem Live-Anruf teilnehmen können, Zugriff haben.
- None.
- None.
Zoom conference call scheduled for 9:00 AM ET
REHOVOT,
Later that day, Company management, will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To join the conference, please register in advance: https://us06web.zoom.us/webinar/register/WN_K5GBuG1FQ7Srbe_UJ7r2iQ
The entire conference will be available online on the company's website a few days after.
About Evogene:
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:
- Biomica Ltd. (www.biomicamed.com) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
- Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI;
- AgPlenus Ltd. (www.agplenus.com) - developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
- Casterra Ag Ltd. (www.casterra.co) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI.
For more information, please visit: www.evogene.com.
Contacts
ir@evogene.com
Tel: +972-8-9311901
Logo - https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/evogene-schedules-second-quarter-2024-financial-results-release-302219765.html
SOURCE Evogene
FAQ
When will Evogene (EVGN) release its Q2 2024 financial results?
What time is Evogene's (EVGN) Q2 2024 earnings conference call scheduled for?
How can investors join Evogene's (EVGN) Q2 2024 earnings conference call?
Will Evogene (EVGN) make its Q2 2024 earnings call available for later viewing?
